Premium
Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety
Author(s) -
Collier Erin K.,
Seivright Justine R.,
Shi Vivian Y.,
Hsiao Jennifer L.
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14674
Subject(s) - hidradenitis suppurativa , medicine , pregnancy , breastfeeding , antiseptic , intensive care medicine , dermatology , disease , obstetrics , pediatrics , pathology , genetics , biology
Hidradenitis suppurativa (HS) is a chronic inflammatory disease that disproportionately affects women of childbearing age. Pregnancy influences HS severity for many women, thus diligent continued management throughout pregnancy and postpartum may be required. Herein, we provide an updated review of pregnancy and lactation safety data for HS medications, including topical antiseptic washes, topical and systemic antibiotics, biologic and nonbiologic immunomodulators, immunosuppressants, adjunct medical therapies, and pain medications, to help guide risk‐benefit discussions between providers and HS patients.